Clinical Trials Browser

Phase 2 × Completed × Anemia, Sickle Cell × Clear all

Anemia, Sickle Cell, Priapism

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

NCT00236041 2014-05-09

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Phase 2 Completed

38 enrolled

Classical hematology

Agnosia, Anemia, Sickle Cell, Burns, Neoplasms, Breakthrough Pain

NCT00236093 2014-05-09

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Phase 2 Completed

Classical hematology

Anemia, Sickle Cell, Burns, Neoplasms, Pain

Clinical Trials

SUSTAIN

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain